David Ian Johnson
CIK 1563432 · Executive Chairman · last filed 2024-10-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$848.0K
Companies
3
Total Filings
24
Lifetime Open-Market Net
$171.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 3
24 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-04-03 | Alliqua BioMedical, Inc. (ALQA) Delisted | Tax (F) | −20,590 | -$106.9K | EDGAR |
| 2015-03-10 | Alliqua BioMedical, Inc. (ALQA) Delisted | Tax (F) | −7,673 | -$40.6K | EDGAR |
| 2015-02-09 | Alliqua BioMedical, Inc. (ALQA) Delisted | Grant (A) | +300,000 | $0 | EDGAR |
| 2015-01-05 | Alliqua BioMedical, Inc. (ALQA) Delisted | Tax (F) | −21,681 | -$114.9K | EDGAR |
| 2014-10-02 | Alliqua BioMedical, Inc. (ALQA) Delisted | Tax (F) | −20,552 | -$99.5K | EDGAR |
| 2014-07-14 | Alliqua BioMedical, Inc. (ALQA) Delisted | Tax (F) | −20,367 | -$116.9K | EDGAR |
| 2014-03-10 | Alliqua BioMedical, Inc. (ALQA) Delisted | Grant (A) | +17,824 | $0 | EDGAR |
| 2014-01-08 | — | Mixed | +350,150 | -$134.5K | |
| 2013-12-24 | — | Grant (A) | — | $0 | |
| 2013-11-15 | — | Grant (A) | — | $0 |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.